首页 / 院系成果 / 成果详情页

RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis. 会议论文

编号：

38bf428a-d232-4094-b16f-1738b7d8add6
作者：

Cosgriff, Thomas; Yang, Lin; Alyasova, Anna; Ye, Dingwei; Karpenko, Andrey; Li, Hanzhong; Alekseev, Boris; Xie, Liping; Kowalyszyn, Ruben Dario; Karyakin, Oleg; Neron, Yeni Veronica; Collins, LaTonya; Brechenmacher, Thomas; Lin, Chinjune; Morgan, Liza; Motzer, Robert J.
作者单位：

Crescent City Res Consortium, Marrero, LA USA; Chinese Acad Med Sci, Canc Hosp & Inst, Peking Union Med Coll, Beijing 100730, Peoples R China; Prevoljskiy Reg Med Ctr, Novgorod, Russia; Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; Leningrad Reg Oncol Dispensary, St Petersburg, Russia; Beijing Union Med Coll Hosp, Beijing, Peoples R China; Natl Med Res Radiol Ctr, Moscow, Russia; Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; Med Radiol Res Ctr, Obninsk, Russia; Ctr Pesquisas Oncol CEPON, Florianopolis, SC, Brazil; Novartis Oncol, E Hanover, NJ USA; Novartis Pharma SAS, Rueil Malmaison, France; Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; Ctr Invest Clin Clin Viedma, Viedma, Argentina
会议名称：

JOURNAL OF CLINICAL ONCOLOGY
会议时间：
出版信息：

2016 年 34 卷 2 期

浏览次数：1  下载次数：0

浏览次数：1

下载次数：0

打印次数：0